Key Takeaway
After 4 months on GLP-1 medications, most patients lose 12 to 25 pounds depending on the medication. Here is a thorough breakdown with clinical data.
Four months into GLP-1 therapy is a significant milestone. Patients researching GLP-1 results after 4 months will find that the results are genuinely impressive at this point, with most patients having lost 12 to 25 pounds depending on the specific medication and dosage . You're now deep into the therapeutic dose range, and the medication is producing its strongest effects.
Where Different GLP-1 Medications Stand at 4 Months
| Medication | Typical Dose at 4 Months | Average Weight Loss | Body Weight % Lost |
|---|---|---|---|
| Semaglutide (Wegovy) | 1.7 mg | 14 to 20 lbs | 6% to 9% |
| Semaglutide (Ozempic) | 1.0 to 2.0 mg | 12 to 18 lbs | 5% to 8% |
| Tirzepatide (Zepbound/Mounjaro) | 10 mg | 16 to 26 lbs | 7% to 11% |
| Liraglutide (Saxenda) | 3.0 mg (max) | 10 to 16 lbs | 5% to 7% |
| Compounded semaglutide | 1.0 to 1.7 mg | 13 to 20 lbs | 5% to 8% |
The differences between medications become more apparent at the four-month mark. Tirzepatide generally leads the pack due to its dual receptor mechanism, while semaglutide-based options produce strong results as patients approach their maximum doses .
What Happens During Month Four
The Acceleration Continues
Month four is typically one of the highest-velocity weight loss months for GLP-1 patients. You have reached or are near therapeutic doses, side effects are manageable, and your body is in a sustained caloric deficit .
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Weeks 13 to 14
- Another dose increase for most patients keeps momentum building
- Weekly weight loss of 1.5 to 2.5 pounds is common
- Physical transformation is clearly visible
- Blood sugar and lipid improvements continue accumulating
Weeks 15 to 16
- Body composition changes become more apparent than weight alone suggests
- Energy levels and mobility are markedly improved
- Many patients have reduced or eliminated other medications (blood pressure, diabetes)
- Psychological relationship with food has fundamentally shifted
Health Improvements Beyond Weight at 4 Months
The four-month mark is when systemic health improvements become medically significant :
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Blood sugar: A1C reductions of 0.8% to 2% for patients with diabetes or prediabetes.
- Blood pressure: Average systolic decrease of 5 to 12 mmHg. Some patients may reduce or stop blood pressure medications.
- Cholesterol: LDL and triglyceride improvements of 10% to 25%. HDL (good cholesterol) often increases.
- Liver health: ALT and AST levels (liver enzymes) often improve as fatty liver disease begins to reverse.
- Inflammation: CRP levels decrease, reflecting reduced systemic inflammation.
- Sleep apnea: Patients with obesity-related sleep apnea often report improved sleep quality and reduced apnea episodes.
Common Challenges at Four Months
While results are exciting, month four also brings some common challenges that are important to address :
- Social pressure: Friends and family commenting on your body can feel uncomfortable. Set boundaries if needed.
- Plateaus: Brief stalls in weight loss are normal and temporary. They don't mean the medication stopped working.
- Undereating: Strong appetite suppression can lead to dangerously low calorie intake. Aim for at least 1200 calories (women) or 1500 calories (men) daily.
- Identity shifts: Rapid physical change can trigger complex emotions. Therapy or support groups can help.
- Cost fatigue: Four months of medication costs can add up. Discuss options like compounded versions with your provider FormBlends pricing.
Strategies for Continued Progress
- Get blood work done. A thorough metabolic panel, lipid profile, and complete blood count are important at this stage.
- Evaluate your exercise routine. Progress from walking to more challenging activities: jogging, cycling, swimming, or strength training programs.
- Consider working with a dietitian. A registered dietitian can help you improve nutrition within your reduced appetite.
- Prioritize sleep. 7 to 9 hours of quality sleep supports weight loss, muscle recovery, and overall health.
- Set a 6-month goal. Having a clear target for the next 8 weeks keeps you focused and motivated.
Frequently Asked Questions
Which GLP-1 produces the best results at 4 months?
Tirzepatide (Zepbound/Mounjaro) produces the highest average weight loss at four months, typically 16 to 26 pounds. Semaglutide (Wegovy/Ozempic) follows closely at 12 to 20 pounds. The best medication for you depends on individual response and tolerability GLP-1 medication comparison.
Is it too late to start exercise at month four?
It's never too late. In fact, month four is an excellent time to start or increase exercise because your lighter body weight makes physical activity more comfortable and enjoyable .
Can I switch medications at 4 months if my results are disappointing?
Yes. If you have been on an adequate dose for at least 8 weeks without meaningful results, your provider may recommend switching. For example, moving from semaglutide to tirzepatide (or vice versa) can sometimes produce better outcomes.
How much more weight will I lose after 4 months?
Most patients continue losing weight through months 8 to 12. The total additional loss depends on your current dose, potential dose increases, and lifestyle factors. Many patients lose an additional 10% to 15% of their starting weight between months 4 and 12 .
Should I be worried about loose skin?
At 15 to 25 pounds of loss, loose skin isn't typically a major concern. It becomes more relevant for patients who lose 50+ pounds. Staying hydrated, eating adequate protein, strength training, and collagen supplementation may help support skin elasticity .